9/14/2025: The Hindu Business: U.S. FDA issues 5 observations to Dr. Reddy’s Hyderabad unit

Posted On By
0 0
Read Time:11 Second

The U.S. Food and Drug Administration (FDA) has issued five observations to the biologics manufacturing facility of generic drugmaker Dr. Reddy’s Laboratories in Hyderabad. The observations followed a pre­approval inspection (PAI) of the facility in…

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *